TC-5619
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for TC-5619, covering 2013-04-30 to 2015-06-03. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy, Safety, and Tolerability of TC-5619 as Augmentation Therapy to Improve Negative Symptoms and Cognition in Outpatients With Schizophrenia [Phase 2]